New York, August 08, 2018: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Medtronic plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Insulin, a glucose managing hormone, assumes a key part in the whole treatment of diabetes. Insulin is in charge of the support of sugar levels in the body and aides in the best possible execution of all physiological and cell exercises. The significant drivers in the market incorporate ideal repayment situation and government bolster in selected economies, innovative advancements in insulin delivery devices, and increasing diabetic populace, unhealthy lifestyles and obesity. Obesity is accepted to be a main cause for the advancement of diabetes in people. Subsequently, the huge populace burdened with diabetes is driving the market for insulin delivery devices. A couple of the significant patterns in the worldwide insulin delivery devices market are artificial pancreas and home infusion treatment. Cost-intensive insulin will however remain a noteworthy test to the market development. Besides, complexity and dangers related with the delivery of insulin are likewise predicted to control the interest for insulin delivery devices.
The scope of the report includes a detailed study of global and regional markets on Global Insulin Delivery Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The Global Insulin Delivery Devices Market is expected to exceed more than US$ 17.00 Billion by 2022 at a CAGR of 9% in the given forecast period.
You Can Browse Full Report: https://www.marketresearchengine.com/insulin-delivery-devices-market
The restraining factors of Global Insulin Delivery Devices Market are as follows:
- Reimbursement structure in developing countries is very poor
- Needle anxiety in patients to affect the growth of the pen needles and syringes market
- Oral insulin as an alternative drug delivery method
- Issues associated with the reuse of pen needles and infusion sets
- Shortage of Endocrinologists
The major driving factors of Global Insulin Delivery Devices Market are as follows:
- Increase diabetic patients
- Development of technological advancements in insulin delivery devices
- Favorable reimbursement environment and government support in selected countries
- Conferences, meetings, and congresses to create awareness about insulin delivery devices
The Global Insulin Delivery Devices Market has been segmented as below:
The Global Insulin Delivery Devices Market is Segmented on the lines of End User Analysis, Type Analysis and Regional Analysis. By End User Analysis this market is segmented on the basis of Patients/Homecare sector and Hospitals & Clinics sector.
By Type Analysis this market is segmented on the basis of Pens its covers Reusable Pens & Disposable Pens. Pumps its covers External/Tethered Pumps & Patch Pumps. Pen Needles its covers Standard Pen Needles & Safety Pen Needles. Syringes and Other Devices. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the world.
This report provides:
1) An overview of the global market for Global Insulin Delivery Devices Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Insulin Delivery Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report from here: https://www.marketresearchengine.com/insulin-delivery-devices-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Insulin Delivery Devices Market, By Type
7 Insulin Delivery Devices Market, By End User
8 Insulin Delivery Devices Market, By Region
9 Competitive Landscape
9.2 Market Share Analysis
9.3 Competitive Situation and Trends
9.3.1 Marketing and Promotion
9.3.2 Agreements, Alliances, Partnerships, Joint Ventures, and Collaborations
9.3.3 Product Launches
9.3.5 Other Strategies
10 Company Profiles
10.2 Becton, Dickinson and Company
10.3 Novo Nordisk A/S
10.4 Medtronic PLC
10.6 ELI Lilly and Company
10.7 Ypsomed Holding AG
10.8 Animas Corporation (Johnson and Johnson)
10.9 Tandem Diabetes Care, Inc.
10.10 Insulet Corporation
10.11 Biocon Limited
Contact Person: John Bay
Country: United States
The post Insulin Delivery Devices Market is Expected to Exceed US$ 17.00 Billion By 2024 appeared first on Herald Keeper.